会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • PYRIMIDINE COMPOUNDS
    • 嘧啶化合物
    • WO2003047516A2
    • 2003-06-12
    • PCT/US2002/038161
    • 2002-11-27
    • SYNTA PHARMACEUTICALS CORPORATIONONO, MitsunoriSUN, LijunPRZEWLOKA, TeresaZHANG, ShijieKOSTIK, ElenaYING, WeiwenWADA, YumikoKOYA, KeizoWU, YamingZHOU, DanTATSUTA, Noriaki
    • ONO, MitsunoriSUN, LijunPRZEWLOKA, TeresaZHANG, ShijieKOSTIK, ElenaYING, WeiwenWADA, YumikoKOYA, KeizoWU, YamingZHOU, DanTATSUTA, Noriaki
    • A61K
    • C07D239/48A61K31/5377A61K31/541C07D401/12C07D401/14C07D403/12
    • This invention features pyrimidine compounds of formula (I): R 1 is formula (II), aryl, or heteroaryl; each of R 2 and R 4 , independently, is R c , halogen, nitro, cyano, isothionitro, SR c , or OR c ; or R 2 and R 4 , taken together, is carbonyl; R 3 is R c , alkenyl, alkynyl, OR c , OC(O)R c , S0 2 R c , S(O)R c , S(0 2 )NR c R d , SR c , NR c R d , NR c COR d , NR c C(O)OR d , NR c C(O)NR c R d , NR c S0 2 R d , COR c , C(O)OR c , or C(O)NR c R d ; R 5 is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; X is O, S, S(O), S(0 2 ), or NR c ; Y is a covalent bond, CH 2 , C(O), C=N-R c , C=N-OR c , C=N-SR c , O, S, S(O), S(0 2 ), or NR c ; Z is N or CH; one of U and V is N, and the other is CR c ; and W is O, S, S(O), S(0 2 ), NR c , or NC(O)R c ; in which each of R a and R b , independently, is H, alkyl, aryl, heteroaryl; and each of R c and R d , independently, is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl. The compounds are useful for treating IL-12 overproduction related diseases (e.g., rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus).
    • 本发明的特征是式(I)的嘧啶化合物:R1是式(II),芳基或杂芳基; 每个R 2和R 4独立地为R c,卤素,硝基,氰基,异硫氰酸根,SR c, sup>或OR c ; 或者R 2和R 4合在一起为羰基; R 3是R c,烯基,炔基,OR c,OC(O)R c,S 0, (O)R c,S(O 2)NR c,其中R 1,R 2, R c,NR c,NR c,NR c,NR c,NR c,NR c R c, (O)OR d,NR c C(O)NR s,C(O)NR c, R c,R c,R c,R c,R c,R c,R c,R c,R c,R c, C(O)OR c或C(O)NR c R d; R 5是H或烷基; n是0,1,2,3,4,5或6; X是O,S,S(O),S(O 2)或NR C; Y是共价键,CH 2,C(O),C = NR c,C = N-OR c,C = N -S(O)S,S(O),S(O 2)或NR C; Z是N或CH; U和V中的一个是N,另一个是CR c ; 和W是O,S,S(O),S(O 2),NR C或NC(O)R C; 其中R a和R b各自独立地为H,烷基,芳基,杂芳基; 并且每个R c和R d独立地为H,烷基,芳基,杂芳基,环基,杂环基或烷基羰基。 该化合物可用于治疗IL-12过量产生相关疾病(例如类风湿性关节炎,败血症,克罗恩氏病,多发性硬化症,牛皮癣或胰岛素依赖性糖尿病)。